<DOC>
	<DOCNO>NCT03094026</DOCNO>
	<brief_summary>A pilot study evaluate feasibility enrollment patient intervention improve neurocognitive function hematopoietic cell transplantation ( HCT ) survivor use cognitive training Lumosity program . In addition , patient ' interest receiving information regard genetic risk cognitive impairment post-HCT measure .</brief_summary>
	<brief_title>Cognitive Training Intervention Attitudes Towards Genetics</brief_title>
	<detailed_description>The investigator propose use `` off-the-shelf '' product - Lumosity ( http : //www.lumosity.com/ ) - online cognitive training program , address cognitive impairment outpatient HCT survivor . The program offer 60 task game-like format cover main cognitive domain : processing speed , work memory , executive function . Training involve daily session 5 training task 12 week . Each time patient log session , customized report generate Lumosity program capture performance information . Ideally , target intervention offering specifically high risk ( integrate clinical genetic marker ) would ensure efficacy . However , evidence lack whether patient receptive communication individual genetic information whether provision result would lead enhanced intervention response . To realize high expectation personalize medicine , patient ' preference attitude need thoroughly investigate especially information genetic risk become available . The investigator examine patient ' genetic knowledge determine whether factual knowledge genetics essential understanding genetic risk inform treatment decision make patient population .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>â‰¥ 21 year old time allogeneic HCT perform UAB Outpatient 3 6 month post HCT English speaking Possess access internetconnected home computer Exclusion criterion : History preexist neurological disorder document major psychiatric disorder ; significant auditory , visual , motor impairment Participated neuropsychological intervention within past 6 month History color blindness</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hematologic cancer</keyword>
	<keyword>Hematopoietic cell transplantation</keyword>
	<keyword>cognitive training</keyword>
	<keyword>genetic knowledge</keyword>
	<keyword>genetic attitude</keyword>
	<keyword>adult cancer survivor</keyword>
</DOC>